Parkinson's disease secondary to 2 mutations of genes involved in lysosomal protein degradation
Main Authors: | G. Fernández-Pajarín, A. Sesar, B. Ares-Pensado, A. Castro |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2020-10-01
|
Series: | Neurología (English Edition) |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2173580820301747 |
Similar Items
-
Enfermedad de Parkinson por sendas mutaciones en 2 genes relacionados con la degradación por lisosomas
by: G. Fernández-Pajarín, et al.
Published: (2020-10-01) -
Do we need to redefine the advanced stage in Parkinson’s disease?
by: Ángel Sesar, et al.
Published: (2021-10-01) -
Intolerance to dopaminergic medication and deep brain stimulation: A report of 3 cases
by: G. Fernández-Pajarín, et al.
Published: (2020-11-01) -
Intolerancia a la medicación dopaminérgica y estimulación cerebral profunda, a propósito de 3 casos
by: G. Fernández-Pajarín, et al.
Published: (2020-11-01) -
VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease
by: Qingmin Ruan, et al.
Published: (2010-02-01)